"Rothman Orthopaedic Institute is a world-leader in the field of orthopaedics serving communities in Pennsylvania, New Jersey, New York and most recently Florida through its new partnership with AdventHealth. Rothman Orthopaedics provides high-quality, compassionate and affordable musculoskeletal care that is grounded in evidence-based medicine. Rothman Orthopaedic Institute is recognized for excellence in clinical treatment methods, research, education and technology with experts in nine orthopaedic sub-specialties including spine, hip and knee, foot and ankle, shoulder and elbow, hand and wrist, sports medicine, physical medicine and rehabilitation, orthopaedic oncology and trauma. For more information please call 800-321-9999."

During the past decade, Rothman Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rothman Institute" #1 collaborator was "Sharpe-Strumia Research Foundation" with 1 trials as a collaborator and "Zimmer Biomet, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rothman Institute" are "Arthroplasty, Replacement, Knee" (1 trials), "Flexion Contracture Following Total Knee Replacement" (1 trials), "Insufficiency Fractures" (1 trials), "Lumbar Spinal Stenosis" (1 trials) and "Neurogenic Claudication" (1 trials). Many other conditions were trialed in "Rothman Institute" in a lesser frequency.

Most popular intervention types in "Rothman Institute" are "Device" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botox" (1 trials), "Control" (1 trials), "Pedicle Lengthening Osteotomy with Altum® Device" (1 trials), "Treatment of insufficiency fractures" (1 trials) and "Zimmer-Biomet Posterior Cruciate Retaining total knee arthroplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rothman Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Rothman Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rothman Institute, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rothman Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".